These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4688816)

  • 1. [Usefulness of EACA in conditions of fibrinolysis activation in obstetrics and gynecology].
    Trebicka-Kwiatkowska B; Radomański T; Ostasz T
    Wiad Lek; 1973 Feb; 26(4):297-303. PubMed ID: 4688816
    [No Abstract]   [Full Text] [Related]  

  • 2. [Contrykal as antifibrinolytic agent in obstetrics and gynecology].
    Flähmig M; Sieg U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):142-50. PubMed ID: 4174652
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epsilon-aminocaproid acid in the treatment of fibrinolysis in gynecologic patients].
    Chyhrynets' II
    Pediatr Akus Ginekol; 1965; 4():50-2. PubMed ID: 5888241
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention and treatment of uterine hemorrhage in obstetrics with epsilon-aminocaproic acid].
    Shilko NA; Borsuk GT; Gurova IF; Zhurbenko IuK; Matsiuk AG; Franchuk AE; Iushchishina SV
    Vopr Okhr Materin Det; 1968 Sep; 13(9):63-7. PubMed ID: 5304942
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of functional uterine hemorrhages with epsilon-aminocapric acid ("EAC", Berlin-Chemie)].
    Linz O
    Dtsch Gesundheitsw; 1967 Sep; 22(35):1652-6. PubMed ID: 5614051
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of dysfunctional uterine hemorrhages by the intrauterine administration of a 10 per cent solution of aminocaprioc acid].
    Davygora LK
    Pediatr Akus Ginekol; 1974; (1):51-4. PubMed ID: 4457801
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of antifibrinolytic agents in obstetrics].
    Vojta M
    Cesk Gynekol; 1970 Jul; 35(6):384-6. PubMed ID: 5311001
    [No Abstract]   [Full Text] [Related]  

  • 8. [Delivery of healthy twins following a successfully treated premature placental detachment occurring at the end of the 6th month. (Case report)].
    Pleissner K
    Z Arztl Fortbild (Jena); 1968 May; 62(9):477-81. PubMed ID: 5697177
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in the euglobulin fibrinolysis time during interruption of pregnancy after intravenous injection of EACA].
    Howorka E; Wyrzykiewicz T
    Wiad Lek; 1968 Jul; 21(13):1129-32. PubMed ID: 5670520
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood coagulation and fibrinolysis of functional uterine hemorrhage].
    Yuki K
    Nihon Sanka Fujinka Gakkai Zasshi; 1967 Mar; 19(3):275-80. PubMed ID: 6070781
    [No Abstract]   [Full Text] [Related]  

  • 11. Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 year's clinical experience.
    Nilsson IM; Andersson L; Björkman SE
    Acta Med Scand Suppl; 1966; 448():1-46. PubMed ID: 5221699
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of epsilon-caproic acid in the treatment of obstetric hypofibrinogenemia].
    Loria Mendez M; Karchmer S; Dominguez JL; Martinez L
    Ginecol Obstet Mex; 1966; 21(125):997-1016. PubMed ID: 5301768
    [No Abstract]   [Full Text] [Related]  

  • 13. Extractions in hemophilia. Use of EACA.
    Short SG; Ogle RG
    Minn Med; 1974 Feb; 57(2):77-80. PubMed ID: 4544337
    [No Abstract]   [Full Text] [Related]  

  • 14. [Administration of epsilon-aminocaproic acid (EACA) in the prevention of fibrinolytic hemorrhages associated with the expulsion of the fetus remaining in the uterus after its death].
    Howorka E; Wyrzykiewicz T
    Wiad Lek; 1970 Jun; 23(11):973-7. PubMed ID: 5426822
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contribution of epsilon aminocaproic acid (Hemocaprol) to the treatment of functional uterine hemorrhages during the premenopausal period].
    Jamon G
    Therapeutique; 1972 Dec; 48(10):717-9. PubMed ID: 4661296
    [No Abstract]   [Full Text] [Related]  

  • 16. [USE OF EPSILON-AMINOCAPROIC ACID (EACA) IN GYNECOLOGY AND OBSTETRICS].
    BAR PRATKOWSKA J; NIEWIAROWSKA M; DOBRACZYNSKA J
    Ginekol Pol; 1964; 35():81-6. PubMed ID: 14126161
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of sigma-aminocaproic acid on blood coagulation and its fibrinolytic activity in vitro].
    Skipetrov VP; Bobrenko GV; Vashchenko TN; Simonova GP
    Probl Gematol Pereliv Krovi; 1970 Jun; 15(6):39-42. PubMed ID: 5471517
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of abnormal uterine bleedings with Acepramine.
    Boros S; Ruzicska G; Dzvonyár J; Gulyás P
    Ther Hung; 1970; 18(1):23-6. PubMed ID: 5423192
    [No Abstract]   [Full Text] [Related]  

  • 19. The in-vivo-effect of E-aminocaproic acid (EACA) on human plasma fibrinolytic system.
    Niewiarowski S; Wolosowicz N
    Thromb Diath Haemorrh; 1966 May; 15(3):491-500. PubMed ID: 4865186
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experience with Epsilamin for functional uterine bleeding].
    Shinagawa N; Nagayama M; Yamada C; Yuki K
    Sanfujinka No Jissai; 1966 Aug; 15(8):747-9. PubMed ID: 6013906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.